Your browser doesn't support javascript.
loading
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.
McConkey, David J; Baumann, Brian C; Cooper Greenberg, Stephanie; DeGraff, David J; Delacroix, Scott E; Efstathiou, Jason A; Foster, Jared; Groshen, Susan; Kadel, Edward E; Khani, Francesca; Kim, William Y; Lerner, Seth P; Levin, Trevor; Liao, Joseph C; Milowsky, Matthew I; Meeks, Joshua J; Miyamoto, David T; Mouw, Kent W; Pietzak, Eugene J; Solit, David B; Sundi, Debasish; Tawab-Amiri, Abdul; West, Pamela J; Wobker, Sara E; Wyatt, Alexander W; Apolo, Andrea B; Black, Peter C.
Afiliación
  • McConkey DJ; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA.
  • Baumann BC; Department of Radiation Oncology, Springfield Clinic, Springfield, IL, USA.
  • Cooper Greenberg S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • DeGraff DJ; Patient Advocate, Baltimore, MD, USA.
  • Delacroix SE; Department of Pathology and Laboratory Medicine, Pennsylvania State University, Hershey, PA, USA.
  • Efstathiou JA; Department of Urology, Pennsylvania State University, Hershey, PA, USA.
  • Foster J; Department of Urology, Louisiana State University Health Science Center, New Orleans, New Orleans, LA, USA.
  • Groshen S; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Kadel EE; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Khani F; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Kim WY; US Medical Affairs and Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Lerner SP; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Levin T; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Liao JC; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Milowsky MI; Convergent Genomics, San Francisco, CA, USA.
  • Meeks JJ; Department of Urology, Stanford University, Stanford, CA, USA.
  • Miyamoto DT; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Mouw KW; Department of Urology, Feinberg School of Medicine, Chicago, IL, USA.
  • Pietzak EJ; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Chicago, IL, USA.
  • Solit DB; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Sundi D; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, USA.
  • Tawab-Amiri A; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • West PJ; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wobker SE; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wyatt AW; Department of Urology, Ohio State University Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, Columbus, OH, USA.
  • Apolo AB; Coordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Black PC; Emmes Company, Rockville, MD, USA.
Bladder Cancer ; 10(1): 1-8, 2024.
Article en En | MEDLINE | ID: mdl-38993535

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Bladder Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Bladder Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos